Pityriasis rosea as a leading manifestation of COVID-19 infection.

To the Editor: Reported cutaneous manifestations incidence during COVID-19 infection varied between countries, a recent review showed a worldwide mean incidence of 1.7%. These manifestations are polymorphic, and vary dependently on the disease severity. Few pityriasis rosea (PR) and PR-like eruptions have been reported during COVID-19 infection.